The role of [18F]FDG PET/CT in multiple myeloma

The role of [18F]FDG PET/CT in multiple myeloma
October 18, 2023 | 12:00 pm ET
AIMN – Italian Association of Nuclear Medicine and Molecular Imaging

Annibale Versari, MD

Annibale Versari, MD

Elena Zamagni, MD, PhD

Course Summary:
The session is addressed to nuclear medicine physicians, radiologists, and oncologists who wish to gain information about the clinical and literature data about the role of Nuclear Medicine in the management of patients affected by multiple myeloma. The role of [18F]FDG PET/CT and [18F]FDG PET/MR imaging will be discussed underlining problems and advantages.  Alternative agents other than [18F]FDG will be considered. 

Course Objectives:

  • Understand the current available data about multiple myeloma and PET.
  • Define the role of PET/CT, PET/MR in managing patients with multiple myeloma.
  • Consider alternative agents for PET imaging able to improve the detection and the management of multiple myeloma.

CE Information:
CE Credit applications for physicians, pharmacists, physicists and technologists are pending. Check back for updates regarding CE Credit status.

10/18/2023 12:00 PM - 2:00 PM

Register for Another Webinar

Sign In to Register